SPM Corp operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SPM Corp with three other
drug stores in Asia:
Mustika Ratu Tbk PT
sales of 344.68 billion Indonesian Rupiahs [US$23.61 million]
New Ray Medicine International Holding Ltd
of Hong Kong
(235.25 million Hong Kong Dollars [US$29.97 million]
of which 97%
was Injection drugs), and
Hin Sang Group (International) Holding Co Ltd
based in Hong Kong
(201.82 million Hong Kong Dollars [US$25.71 million]
of which 89%
was Product Development Segment).
SPM Corp reported sales of 636.02 billion Dong (US$27.29 million)
December of 2017.
increase of 38.0%
versus 2016, when the company's sales were 460.76 billion Dong.